CoreCap Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

CoreCap Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$63	Buy	+1	New	+$66	﹤0.01%	2329
2022 Q3	–	Sell	-1	Closed	–	–	2204
2022 Q2	$0	Buy	+1	New	+$55	﹤0.01%	2307
2022 Q1	–	Sell	-1	Closed	-$1K	–	2201
2021 Q4	$1K	Buy	+1	New	+$61	﹤0.01%	2308

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

CoreCap Advisors's AXNX Position: Q4 2022 in Review

CoreCap Advisors opened a new position in Axonics, Inc. Common Stock (AXNX) in Q4 2022: 1 share worth $63. The stake represents ﹤0.01% of the portfolio and ranks #2329 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in AXNX as recently as Q2 2022.

CoreCap Advisors first reported a position in AXNX in Q4 2021 and has held it in 3 quarters since. The position peaked at $1K in Q4 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q4 2022.

CoreCap Advisors held 1 share of Axonics, Inc. Common Stock worth $63 as of Q4 2022.
Axonics, Inc. Common Stock was a new CoreCap Advisors position in Q4 2022.
Axonics, Inc. Common Stock made up ﹤0.01% of CoreCap Advisors's portfolio in Q4 2022, its #2329 holding.
CoreCap Advisors first reported a position in Axonics, Inc. Common Stock in Q4 2021 and has held it in 3 quarters since.
CoreCap Advisors's Axonics, Inc. Common Stock position peaked at $1K in Q4 2021.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2022.

Based on CoreCap Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.